Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Economic Status* ; Health Expenditures*; Neoplasms/*economics ; Neoplasms/*therapy ; Terminal Care/*economics; Aged ; Aged, 80 and over ; Female ; Health Care Costs ; Humans ; Income ; Male ; Republic of Korea ; Retrospective Studies

Backgrounds: A desire for better outcome influences cancer patients' willingness to pay. Whilst cancer-related costs are known to have a u-shaped distribution, the actual level of healthcare utilized by patients may vary depending on income and ability to pay. This study examined patterns of healthcare expenditures in the last year of life in patients with gastric, colorectal, lung, and liver cancer and analyzed whether differences exist in the level of end-of-life costs for cancer care according to economic status.
Methods: This study is a retrospective cohort study which used data from the Korean National Elderly Sampled Cohort, 2002 to 2015. End-of-life was defined as 1 year before death. Economic status was classified into three categorical variables according to the level of insurance premium (quantiles). The relationship between the dependent and independent variables were analyzed using multiple gamma regression based on the generalized estimated equation (GEE) model.
Results: This study included 3083 cancer patients, in which total healthcare expenditure was highest in the high-income group. End-of-life costs increased the most in the last 3 months of life. Compared to individuals in the 'middle' economic status group, those in the 'high' economic status group (RR 1.095, 95% CI 1.044-1.149) were likely to spend higher amounts. The percentage of individuals visiting a general hospital was highest in the 'high' economic status group, followed by the 'middle' and 'low' economic status groups.
Conclusion: Healthcare costs for cancer care increased at end-of-life in Korea. Patients of higher economic status tended to spender higher amounts of end-of-life costs for cancer care. Further in-depth studies are needed considering that end-of-life medical costs constitute a large proportion of overall expenditures. This study offers insight by showing that expenditures for cancer care tend to increase noticeably in the last 3 months of life and that differences exist in the amount spent according economic status.
(© 2022. The Author(s).)

Asia Pac J Clin Oncol. 2012 Sep;8(3):282-91. (PMID: 22898238)
Br J Cancer. 2016 May 24;114(11):1286-92. (PMID: 27070711)
Nurs Econ. 2005 Jul-Aug;23(4):173-80, 147. (PMID: 16189982)
Inquiry. 2019 Jan-Dec;56:46958019880696. (PMID: 31583928)
Health Aff (Millwood). 2017 Jul 1;36(7):1218-1226. (PMID: 28679808)
BMC Palliat Care. 2020 Mar 23;19(1):35. (PMID: 32293403)
BMJ Open. 2019 Jul 9;9(7):e024344. (PMID: 31289051)
Transl Clin Pharmacol. 2019 Dec;27(4):115-118. (PMID: 32095477)
Soc Sci Med. 2006 Oct;63(7):1720-31. (PMID: 16781037)
Health Aff (Millwood). 2016 Jul 1;35(7):1189-96. (PMID: 27385233)
J Pain Symptom Manage. 2016 Oct;52(4):498-506. (PMID: 27401513)
Cancer Res Treat. 2016 Jan;48(1):365-75. (PMID: 25761472)
Ann Geriatr Med Res. 2020 Sep;24(3):181-186. (PMID: 32842717)
Med Care. 2009 Jul;47(7 Suppl 1):S56-63. (PMID: 19536010)
Cancer Res Treat. 2015 Oct;47(4):555-63. (PMID: 25687851)
J Clin Oncol. 2003 Mar 15;21(6):1133-8. (PMID: 12637481)
Cancer Res Treat. 2015 Jul;47(3):387-98. (PMID: 25672582)
PLoS One. 2015 Mar 26;10(3):e0121759. (PMID: 25811195)
J Natl Cancer Inst. 2008 May 7;100(9):630-41. (PMID: 18445825)
N Engl J Med. 2012 Jun 7;366(23):2207-14. (PMID: 22646510)
Eur J Cancer. 2001 Sep;37(14):1746-51. (PMID: 11549427)
Health Serv Res. 2015 Jun;50(3):690-709. (PMID: 25424134)
PLoS One. 2019 Dec 23;14(12):e0227007. (PMID: 31869381)
Lancet Public Health. 2021 Mar;6(3):e155-e163. (PMID: 33571459)
Health Serv Manage Res. 2017 Nov;30(4):197-212. (PMID: 29034727)
Eur J Health Econ. 2021 Dec 2;:. (PMID: 34853930)
Annu Rev Sociol. 2010 Aug;36:349-370. (PMID: 21909182)
Lancet Oncol. 2013 Nov;14(12):1165-74. (PMID: 24131614)

Keywords: Cancer patients; Economic status; End-of-life; Healthcare disparities; Healthcare expenditure

Date Created: 20220323 Date Completed: 20220329 Latest Revision: 20220329

20231215

PMC8939210

10.1186/s12885-022-09373-y

35317774